Ozempic

As the Ozempic craze pushes advancements in weight-management medicine forward, pharmaceutical company Novo Nordisk, the company behind the so-called “miracle-drug,” is continuing to crack down on off-brand semaglutide products they say put patients in danger. The drug company announced Wednesday it has filed 12 legal actions in all against medical spas and compounding pharmacies they accuse of selling drugs with FDA-banned chemicals — and will continue to seek injunctions through the court until the practice stops.…

The conversation over weight loss and cutting down fat never really seems to fade with time. More recently, people have been leaning towards alternative methods to shed pounds faster. Drugs like Ozempic and Wegovy are becoming more popular by the day. While these injectable drugs are primarily used as a treatment for diabetes, many resort to them because of their ability to curb hunger, leading to a drop in weight. Although several celebrities have acknowledged using injectables to lose weight, many have opted to simply…

New research has found that patients taking the weight-loss and diabetes drug semaglutide had significantly reduced symptoms of alcohol use disorder. Although the study was small, larger studies are underway with the potential to lead to the use of drugs like semaglutide to treat addiction.It’s fair to say that semaglutide, sold variously as Ozempic, Mounjaro and Wegovy, has taken the world by storm. Initially developed as a treatment to manage blood sugar levels in type 2 diabetics, early testing of the drug demonstrated…

A pharmacist displays a box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and made by Lilly at Rock Canyon Pharmacy in Provo, Utah, May 29, 2023.George Frey | ReutersThe blockbuster diabetes drug Mounjaro is more effective for weight loss than another highly popular treatment, Ozempic, in overweight or obese adults, according to a large analysis of real-world data published Monday.Patients taking Eli Lilly's Mounjaro were significantly more likely to lose weight and saw larger reductions in…

Germany is mulling a ban on…

A clinical trial has found that the cardiovascular benefits that the drug semaglutide affords to overweight or obese type 2 diabetics extend to those without diabetes as well. The study suggests that the drug offers a new way to reduce the potentially deadly risks associated with obesity and being overweight in non-diabetics.Semaglutide, sold as Ozempic and Wegovy, started life as a medication to improve blood glucose control in adults with type 2 diabetes, before being approved by the FDA in 2021 for use as a weight…

Zepbound’s approval was based on trials run by Eli Lilly that included 2,539 adults with obesity or excess weight and weight-related medical problems other than diabetes, according to the company. In those studies, people taking Zepbound who also made diet and exercise changes experienced substantial weight loss at 72 weeks compared with those on a placebo. At the highest dose of 15 milligrams, people taking Zepbound lost an average of 48 pounds. At the lowest dose of 5 milligrams, people lost an average of 34. Those…

…

UK regulators are investigating the Ozempic and Saxenda weight loss drugs over reports that patients experienced suicidal and self-harming thoughts while taking the medications. The drugs skyrocketed in popularity in the U.S. as doctors began prescribing them to people who struggled with obesity, but new reports are coming to light that the so-called miracle drugs may not be such a miracle after all.Samsung Galaxy Fold 5: Hands-on first Impressions of Samsung's Big-Screen Flagship FoldableThe Food and Drug Administration…

Corlee Morris has dieted throughout her adult life. After her weight began climbing in high school, she spent years losing 50 or 100 pounds then gaining it back. Morris, 78, was at her heaviest in her mid-40s, standing 5 feet 10½ inches and weighing 310 pounds. The Pittsburgh resident has had diabetes for more than 40 years. Managing her weight was a losing battle until Morris’ doctor prescribed a Type 2 diabetes medication, Ozempic, four months ago. It’s one in a new category of medications changing how ordinary people…